Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Incannex Healthcare (IXHL) over the last 4 years, with Q4 2025 value amounting to $1.5 million.

  • Incannex Healthcare's Total Current Liabilities fell 7351.03% to $1.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 million, marking a year-over-year decrease of 7351.03%. This contributed to the annual value of $7.0 million for FY2025, which is 2427.05% up from last year.
  • According to the latest figures from Q4 2025, Incannex Healthcare's Total Current Liabilities is $1.5 million, which was down 7351.03% from $1.6 million recorded in Q3 2025.
  • Incannex Healthcare's 5-year Total Current Liabilities high stood at $9.2 million for Q3 2024, and its period low was $1.5 million during Q4 2025.
  • For the 3-year period, Incannex Healthcare's Total Current Liabilities averaged around $4.9 million, with its median value being $5.6 million (2024).
  • The largest annual percentage gain for Incannex Healthcare's Total Current Liabilities in the last 5 years was 15726.26% (2025), contrasted with its biggest fall of 8214.9% (2025).
  • Incannex Healthcare's Total Current Liabilities (Quarter) stood at $3.2 million in 2023, then skyrocketed by 83.3% to $5.8 million in 2024, then plummeted by 73.51% to $1.5 million in 2025.
  • Its Total Current Liabilities stands at $1.5 million for Q4 2025, versus $1.6 million for Q3 2025 and $7.0 million for Q2 2025.